You are here

Drug industry faces era of moderate price increases, says Valeant CEO

New York

VALEANT Pharmaceuticals International, which has been criticised for raising drug prices and is being investigated by the US government, predicted this week that lower price increases are ahead for the whole industry.

Valeant chief executive J Michael Pearson told

Market voices on:


Receive $80 Grab vouchers valid for use on all Grab services except GrabHitch and GrabShuttle when you subscribe to BT All-Digital at only $0.99*/month.

Find out more at

Powered by GET.comGetCom